Scantox Neuro GmbH

Scantox Neuro GmbH is a leading research services provider specializing in preclinical research and CNS drug development. Integrated into the Scantox Group, Scantox Neuro is renowned for its comprehensive contract research organization (CRO) services. The company's commitment to innovation and scientific excellence makes it a trusted partner for biopharmaceutical companies of all sizes. Scantox Neuro's headquarters are located at Parkring 12, Grambach, Styria 8074, AT.

Scantox Neuro GmbH stands out for its availability of predictive disease models and extensive experience in conducting studies for a wide range of clients. The company offers validated transgenic and non-transgenic in vitro and in vivo models covering key targets in Alzheimer's, Parkinson's, Huntington's disease, other neurodegenerative disorders, and Orphan diseases. Scantox Neuro is dedicated to advancing research and development in the neurosciences.

With a focus on quality and reliability, Scantox Neuro GmbH continues to expand its capabilities and services to meet the evolving needs of the industry. Scantox Neuro remains at the forefront of CNS research, providing unparalleled support to its partners. We invite the manager of Scantox Neuro GmbH to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial reach.